Jean-Paul Clozel
Jean-Paul Clozel is a prominent Swiss biopharmaceutical entrepreneur best known as the co-founder of Actelion Pharmaceuticals, which was sold to Johnson & Johnson for $30 billion in 2017. He and his wife, Martine Clozel, established Actelion in 1997 after leaving Roche, driven by their commitment to develop treatments for pulmonary hypertension. Despite health challenges in recent years, he continues to lead Idorsia, their second venture, where he has invested significantly, striving to overcome current financial difficulties.
Not in the pool (under ¢1).
Recent news mentions
Jean-Paul Clozel is a co-founder of Idorsia and has a history of successfully building and selling companies.
Vas Narasimhan und Srishti Gupta
Switzerland· 2025-06-15
Jean-Paul Clozel is a long-time leader at Idorsia and has been known for his strong management style.
Die Frau von Vas Narasimhan wird Idorsia-ChefinSwitzerland· 2025-06-10
Jean-Paul Clozel is a co-founder of Actelion and currently involved with Idorsia, facing challenges in the biotech industry.
Mit Idorsia kommt das Ehepaar Clozel nicht vom FleckSwitzerland· 2025-05-22
